About Laurus Labs
Laurus Labs is a company based in Hyderabad (India) founded in 2005 by Subodh Singh.. Laurus Labs has raised $229.73 million across 3 funding rounds from investors including Warburg Pincus, Aptuit and Eight Roads Ventures. The company has 12,470 employees as of March 31, 2024. Laurus Labs has completed 2 acquisitions, including Laurus Bio and Richcore Lifesciences. Laurus Labs operates in a competitive market with competitors including Symbiotec, Sterling Pharma Solutions, Provepharm Life Solutions, Jubilant Pharma and SeQuent, among others.
- Headquarter Hyderabad, India
- Employees 12470 as on 31 Mar, 2024
- Founders Subodh Singh
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Laurus Labs Ltd.
-
Annual Revenue
$648.83 M (USD)10.18as on Mar 31, 2024
-
Net Profit
$41.82 M (USD)123.18as on Mar 31, 2024
-
EBITDA
$126.64 M (USD)34.79as on Mar 31, 2024
-
Total Equity Funding
$229.73 M (USD)
in 3 rounds
-
Latest Funding Round
$89.73 M (USD), Private Equity Round
Oct 29, 2014
-
Investors
Warburg Pincus
& 2 more
-
Employee Count
12470
as on Mar 31, 2024
-
Investments & Acquisitions
Laurus Bio
& 1 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Laurus Labs
Laurus Labs is a publicly listed company on the NSE with ticker symbol LAURUSLABS in India, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Unlock access to complete
Unlock access to complete
Funding Insights of Laurus Labs
Laurus Labs has successfully raised a total of $229.73M across 3 strategic funding rounds. The most recent funding activity was a Private Equity Round round of $89.73 million completed in October 2014. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Private Equity Round — $89.7M
-
First Round
First Round
(19 Jun 2007)
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2014 | Amount | Private Equity Round - Laurus Labs | Valuation |
investors |
|
| Jun, 2012 | Amount | Private Equity Round - Laurus Labs | Valuation |
investors |
|
| Jun, 2007 | Amount | Private Equity Round - Laurus Labs | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Laurus Labs
Laurus Labs has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include Warburg Pincus, Aptuit and Eight Roads Ventures. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Multi-stage private equity investments are pursued across diverse sectors.
|
Founded Year | Domain | Location | |
|
Venture capital investment and global platform support for startups.
|
Founded Year | Domain | Location | |
|
Contract research and development services for small molecules are offered.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Laurus Labs
Laurus Labs has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Laurus Bio and Richcore Lifesciences. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Precision fermentation services for biopharma and food are provided.
|
2005 | ||||
|
Developer of enzymes for industrial solutions
|
2001 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Laurus Labs
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Laurus Labs Comparisons
Competitors of Laurus Labs
Laurus Labs operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Symbiotec, Sterling Pharma Solutions, Provepharm Life Solutions, Jubilant Pharma and SeQuent, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Non-sterile steroid hormone-based APIs and intermediates are manufactured.
|
|
| domain | founded_year | HQ Location |
Contract development, manufacturing, and analytical services for APIs are offered.
|
|
| domain | founded_year | HQ Location |
APIs and drug products are developed and valorized in pharmaceuticals.
|
|
| domain | founded_year | HQ Location |
Pharmaceuticals, APIs, and radiopharmaceuticals are manufactured by the company.
|
|
| domain | founded_year | HQ Location |
APIs are developed and manufactured for therapeutic areas.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Laurus Labs
Frequently Asked Questions about Laurus Labs
When was Laurus Labs founded?
Laurus Labs was founded in 2005 and raised its 1st funding round 2 years after it was founded.
Where is Laurus Labs located?
Laurus Labs is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
Who is the current CEO of Laurus Labs?
Subodh Singh is the current CEO of Laurus Labs. They have also founded this company.
Is Laurus Labs a funded company?
Laurus Labs is a funded company, having raised a total of $229.73M across 3 funding rounds to date. The company's 1st funding round was a Private Equity Round of $100M, raised on Jun 19, 2007.
How many employees does Laurus Labs have?
As of Mar 31, 2024, the latest employee count at Laurus Labs is 12,470.
What is the annual revenue of Laurus Labs?
Annual revenue of Laurus Labs is $648.83M as on Mar 31, 2024.
What does Laurus Labs do?
Founded in 2005 and based in Hyderabad, India, operations are conducted in the pharmaceutical and biotechnology sectors. Active pharmaceutical ingredients are produced for antiretrovirals, hepatitis, oncology, cardiovascular, and anti-diabetic treatments. Generic formulations, custom synthesis solutions, veterinary APIs, and agro chemicals are also manufactured. Specialty ingredients for nutraceuticals, dietary supplements, and cosmeceutical products are developed.
Who are the top competitors of Laurus Labs?
Laurus Labs's top competitors include Symbiotec, Sterling Pharma Solutions and Provepharm Life Solutions.
Is Laurus Labs publicly traded?
Yes, Laurus Labs is publicly traded on NSE under the ticker symbol LAURUSLABS.
How many acquisitions has Laurus Labs made?
Laurus Labs has made 2 acquisitions, including Laurus Bio, and Richcore Lifesciences.
Who are Laurus Labs's investors?
Laurus Labs has 3 investors. Key investors include Warburg Pincus, Aptuit, and Eight Roads Ventures.
What is Laurus Labs's ticker symbol?
The ticker symbol of Laurus Labs is LAURUSLABS on NSE.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.